EIGER BIOPHARMACEUTICALS INC shareholders Q1 2023

EIGER BIOPHARMACEUTICALS INC's ticker is EIGR and the CUSIP is 28249U105. A total of 72 filers reported holding EIGER BIOPHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.16 and the average weighting 0.0%.

EIGER BIOPHARMACEUTICALS INC shareholders Q1 2023
NameSharesValueWeighting ↓
JPMORGAN CHASE & CO 230,667$207,0000.00%
AQR Capital Management 195,665$175,4920.00%
BARCLAYS PLC 21,271$190.00%
ROYAL BANK OF CANADA 3,093$3,0000.00%
VANGUARD GROUP INC 2,168,404$1,944,8410.00%
Ameritas Investment Partners, Inc. 3,108$2,7880.00%
JANE STREET GROUP, LLC 56,661$50,8190.00%
VOYA INVESTMENT MANAGEMENT LLC 20,985$18,8210.00%
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM 15,498$13,9000.00%
UBS Group AG 13,597$12,1970.00%
ALLIANCEBERNSTEIN L.P. 43,300$38,8360.00%
RHUMBLINE ADVISERS 55,477$500.00%
PRINCIPAL FINANCIAL GROUP INC 13,509$12,1170.00%
BNP PARIBAS FINANCIAL MARKETS 65,702$58,9280.00%
External links

This page lists EIGER BIOPHARMACEUTICALS INC's shareholders in Q1 2023. To view EIGER BIOPHARMACEUTICALS INC's shareholder history, click here.